Completed

MaSSCharacterization and Prevalence of Sarcopenia in Community-Dwelling Older People

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe and compare the nutritional status and physical activity levels of older people living in the community who have sarcopenia, a condition characterized by loss of muscle mass and strength, with those who do not have sarcopenia.

What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
DNA Samples
Who is being recruted

Atrophy+6

+ Muscular Atrophy

+ Nervous System Diseases

From 65 to 99 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Observational
Study Start: May 2013
See protocol details

Summary

Principal SponsorMaastricht University Medical Center
Last updated: January 20, 2016
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2013

Actual date on which the first participant was enrolled.

Characterization of sarcopenic older people (demographics, nutritional status, level of physical activity) Prevalence rates of sarcopenia in community-dwelling older people in the Netherlands Insight in differences and/or overlap between sarcopenia versus frailty Insight in the impact of sarcopenia on economic outcomes

NCT01820988
Principal SponsorMaastricht University Medical Center
Last updated: January 20, 2016
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

247 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 65 to 99 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

AtrophyMuscular AtrophyNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathological Conditions, AnatomicalNeuromuscular ManifestationsSarcopenia

Criteria

4 inclusion criteria required to participate
>= 65 years old
Able to perform a walk test
Have given informed consent
Understand Dutch language
3 exclusion criteria prevent from participating
Older people in a wheelchair, with ICD or pacemaker
Older people living in a nursing home
Older people with active rheumatoid arthritis, post stroke status with evident lingering symptoms (paralysis, loss of motor functions), diseases of the nervous system like Parkinson and MS, active angina pectoris, dementia

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Maastricht University

Maastricht, NetherlandsOpen Maastricht University in Google Maps
CompletedOne Study Center